{"nct_id":"NCT03099161","title":"Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062)","status":"TERMINATED","status_verified_date":"2019-02","start_date":"2017-06-27","start_date_type":"ACTUAL","primary_completion_date":"2017-11-24","primary_completion_date_type":"ACTUAL","completion_date":"2018-02-21","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}